Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

PBI-4050 demonstrates promising antifibrotic properties in vivo

June 11, 2013

La Jolla Pharmaceutical submits IND to the FDA for LJPC-501

June 5, 2013

Otsuka files application in Japan for tolvaptan in autosomal dominant polycystic kidney disease

June 3, 2013

Targacept reports commencement of phase IIb TC-5214 study

May 31, 2013

Data show GCS-100 may improve renal function

May 27, 2013

Netherlands first to approve Vesomni

May 23, 2013

Dosing completed in phase I TTI-1612 study

May 17, 2013

Mirabegron/solifenacin as an effective therapeutic option for overactive bladder

May 16, 2013

Fedovapagon effectively reduces nocturia in men with BPH

May 15, 2013

Relypsa completes enrollment in pivotal phase III trial of patiromer

May 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...